GSTs are associated with cancer through their role in detoxifying carcinogens, drugs, and products of oxidative stress. Abnormalities in GST expression or activity can influence cancer risk, progression, and response to treatment. Elevated levels of certain GST isoforms have been observed in various cancers, contributing to drug resistance and poor prognosis.
